X
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
Other Suppliers
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
U.S. Medicaid
Annual Reports
0
0
https://endpts.com/novartis-wins-one-patent-case-loses-another-over-blockbuster-entresto/
https://www.novartis.com/news/media-releases/novartis-will-appeal-us-court-appeals-uphold-validity-entresto-combination-patent-maintains-2023-guidance-and-mid-term-outlook
https://www.novartis.com/news/media-releases/novartis-entresto-receives-positive-chmp-opinion-pediatric-heart-failure#:~:text=Basel%2C%2031%20March%2C%202023%20%E2%80%94,heart%20failure%20with%20left%20ventricular
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/hc-reserves-order-on-natcos-plea-over-patent-for-novartis-drug/articleshow/96920043.cms?utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/jb-pharma-cuts-price-of-its-top-selling-heart-failure-drug-azmarda-by-50/articleshow/96006616.cms
https://www.fiercepharma.com/pharma/novartis-aiming-block-entresto-generics-files-another-lawsuit-against-mylan-pharmaceuticals
https://www.fiercepharma.com/pharma/novartis-hit-entresto-patent-suit-amid-legal-fights-against-generic-makers
https://www.reuters.com/business/healthcare-pharmaceuticals/novartis-earnings-edge-higher-cosentyx-entresto-2022-04-26/
https://endpts.com/novartis-petitions-fda-to-block-18-generic-competitors-for-its-megablockbuster-heart-drug-until-2024/
https://www.fiercepharma.com/pharma/novartis-targets-20-blockbuster-launches-by-2026-to-drive-growth-beyond-entresto-patent
https://www.fiercepharma.com/pharma/new-data-lilly-and-boehringer-ingelheim-s-jardiance-may-be-answer-for-those-intimately
https://www.bloomberg.com/news/articles/2021-10-28/novartis-cooperating-with-u-s-probe-into-marketing-of-entresto
https://www.statnews.com/pharmalot/2021/10/27/novartis-entresto-justice-department/
https://www.fiercepharma.com/pharma/novartis-hits-doj-probe-into-entresto-marketing-dials-up-peak-sales-estimate-anyway
https://www.novartis.com/news/novartis-entresto-indicated-treatment-hypertension-china
https://www.biopharmadive.com/news/fda-entresto-novartis-expand-approval-heart-failure/595168/
https://www.fiercepharma.com/pharma/novartis-blockbuster-heart-med-entresto-snags-fda-approval-larger-patient-group
https://www.prnewswire.com/news-releases/novartis-entresto-granted-expanded-indication-in-chronic-heart-failure-by-fda-301229375.html
https://www.reuters.com/article/us-novartis-heart-failure/novartis-bid-to-boost-entresto-sales-beyond-5-billion-gets-fda-panel-lift-idUSKBN28Q0NB
https://www.prnewswire.com/news-releases/novartis-announces-positive-fda-advisory-committee-recommendation-for-use-of-entresto-to-treat-patients-with-hfpef-301193607.html
https://www.prnewswire.com/news-releases/study-shows-taking-entresto-as-prescribed-associated-with-lowering-total-cost-of-care-by-6-7-million-301155629.html
https://www.FIERCE PHARMA.com/pharma/esc-novartis-entresto-tallies-a-win-anticipated-heart-failure-trial-but-it-s-a-mixed-one
https://www.fiercepharma.com/pharma/esc-eli-lilly-boehringer-s-jardiance-cuts-cv-events-by-25-farxiga-matching-heart-failure
https://www.fiercepharma.com/marketing/novartis-entresto-picks-up-steam-cardiologists-despite-stinging-loss-desired-heart
https://www.otsuka.co.jp/en/company/newsreleases/2020/20200302_1.html
https://endpts.com/once-again-novartis-cardio-team-looks-to-beat-the-odds-using-sketchy-data-and-a-familiar-argument/
https://endpts.com/once-again-novartis-cardio-team-looks-to-beat-the-odds-using-sketchy-data-and-a-familiar-argument/
https://www.fiercepharma.com/pharma/novartis-narasimhan-wraps-up-eventful-first-year-as-ceo-rosy-outlook-planned
http://www.pmlive.com/pharma_news/novartis_aims_for_10_blockbuster_launches_by_2020_1276765
http://www.pharmafile.com/news/519333/novartis-entresto-tops-enalapril-stabilised-heart-failure-patients
https://www.prnewswire.com/news-releases/new-novartis-study-supports-entresto-as-foundational-hfref-therapy-and-in-hospital-initiation-in-appropriate-stabilized-heart-failure-patients-300748028.html
https://www.fiercepharma.com/manufacturing/tainted-valsartan-has-been-market-four-years-fda-discovers
https://www.swissmedic.ch/swissmedic/en/home/news/mitteilungen/valsartane-recall-update-productoverview.html
http://www.pharmafile.com/news/517073/novartis-entresto-helps-preserve-kidney-function-chronic-heart-failure-patients
https://www.in-pharmatechnologist.com/Article/2018/03/12/Renewed-interest-in-understudied-co-crystals-to-drive-better-meds-says-scientist
http://www.fiercepharma.com/corporate/after-a-slow-start-novartis-gains-market-traction-heart-drug-entresto
http://www.foxbusiness.com/features/2017/08/15/when-new-and-improved-fails-insulin-maker-2.html
http://www.pmlive.com/pharma_news/cv_data_sets_up_novartis_ilaris_for_blockbuster_sales_1196914
http://www.pmlive.com/pharma_news/new_drugs_cant_keep_novartis_sales_on_the_up_1191795
Market Place
Share 
